Digirad (DRAD) Stock Price, News & Analysis

Company Overview

Digirad Corporation provides healthcare solutions in the United States and internationally. It operates through five segments: Diagnostic Services, Diagnostic Imaging, Mobile Healthcare, Building and Construction, and Real Estate and Investments. The company offers imaging and monitoring services to healthcare providers; and contract diagnostic imaging, including computerized tomography (CT), magnetic resonance imaging, positron emission tomography (PET), PET/CT, and nuclear medicine and healthcare services to hospitals, integrated delivery networks, and federal institutions on a long-term contract basis, as well as provisional services to institutions that are in transition. It also develops, sells, and maintains solid-state gamma cameras, such as nuclear cardiac imaging systems and general purpose nuclear imaging systems to physician offices and hospitals; and offers camera maintenance contract services. In addition, it manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; and manages real estate assets and investments. Digirad Corporation was founded in 1985 and is headquartered in Suwanee, Georgia.

Key Stats

• Today's Range: $2.12 to $2.27
• 50-Day Range: $2.79 to $4.65
• 52-Week Range: $1.99 to $8.84
• Volume: 4,354 shs
• Average Volume: 485,592 shs
• Market Capitalization: $10.42 million
• P/E Ratio: N/A
• Dividend Yield: 100.46%
• Price Target: N/A
• Consensus Rating: N/A

DRAD Stock Analysis - Frequently Asked Questions

How were Digirad's earnings last quarter?

Digirad Co. (NASDAQ:DRAD) posted its quarterly earnings results on Wednesday, November, 18th. The medical equipment provider reported ($0.19) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.15 by $0.34. The medical equipment provider earned $30.35 million during the quarter. Digirad had a negative net margin of 5.32% and a negative trailing twelve-month return on equity of 3.75%.

When did Digirad's stock split?

Digirad's stock reverse split before market open on Wednesday, June 5th 2019. The 1-10 reverse split was announced on Friday, May 31st 2019. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, June 4th 2019. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What other stocks do shareholders of Digirad own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Digirad investors own include AT&T (T), General Electric (GE), Gilead Sciences (GILD), Biocept (BIOC), Exelixis (EXEL), Pfizer (PFE) and Rigel Pharmaceuticals (RIGL).

Company Calendar

• Last Earnings: 11/18/2020
• Today: 2/22/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Electromedical Equipment
• Sub-Industry: N/A
• Current Symbol: NASDAQ:DRAD
• CUSIP: N/A
• CIK: 707388
• Web: www.digirad.com
• Phone: 858-726-1600
• Fax: N/A
• Employees: 618
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.35)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-4,630,000.00
• Net Margins: -5.32%
• Pretax Margin: N/A
• Return on Equity: -3.75%
• Return on Assets: -0.85%

Debt

• Debt-to-Equity Ratio: 0.88
• Current Ratio: 1.27
• Quick Ratio: 0.91

Sales & Book Value

• Annual Sales: $114.18 million
• Price / Sales: 0.09
• Cash Flow: $3.17 per share
• Price / Cash Flow: 0.69
• Book Value: $10.30 per share
• Price / Book: 0.21

Miscellaneous

• Outstanding Shares: 4,760,000
• Free Float: N/A
• Market Cap: $10.42 million
• Optionable: Not Optionable
• Beta: 0.18